NR 601 Midterm Exam Study Guide: Changes with Aging, Exams of Nursing

This study guide provides a comprehensive overview of physiological changes associated with aging, focusing on the impact on drug pharmacokinetics and pharmacodynamics. It explores how these changes affect drug absorption, distribution, metabolism, and elimination, highlighting the importance of considering age-related factors in medication management. The guide also discusses the altered presentation of illness and disease in older adults, emphasizing the need for a nuanced approach to diagnosis and treatment. It concludes with review questions to reinforce key concepts.

Typology: Exams

2024/2025

Available from 12/24/2024

nursinghero
nursinghero 🇬🇧

2

(4)

1.5K documents

1 / 13

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
NR 601 MIDTERM EXAM STUDY GUIDE
2023
NR 601
Chapter 1: Changes with Aging - Notes
Fundamental Considerations
- Recognize that presenting features of disease/illness may be different and having a greater awareness of
the impact of chronic illness on the patient.
- Perspective is different than with younger adults.
Physiological Changes with Aging
- The clinician must be aware that all the systems interact an, in doing so, can increase the older
person’s vulnerability to illness/disease.
- During the clinical decision-making process, the clinician knowledgeable about physiological changes with
aging will be less likely to undertreat a treatable condition. -Example- Use the diagnostic process to
differentiate the more benign seborrheic keratosis from actinic keratosis.
- Be informed; do not attribute a finding to the aging process alone. The elder may conclude there is no point
in changing behavior, because the process is inevitable.
- Three primary points:
1) There is a reduced physiological reserve of most body systems, particularly cardiac, respiratory, and renal.
2) There are reduced homeostatic mechanisms that fail to adjust regulatory systems such as temperature
control and fluid and electrolyte balance.
3) There is impaired immunological function: infection risk is greater, and autoimmune diseases are
more prevalent.
Laboratory Values in Older Adults
- Many factors can influence lab value interpretation in the elderly, including the physiological changes with
aging, the prevalence of chronic disease, changes in nutritional and fluid intake, lifestyle (including activity), and
the medications taken.
- Reference ranges therefore may be preferable. Reference ranges or intervals, such as age, sex, or race can be
defined demographically. For example, the reference range for older adults might be the intervals within which
95% of persons over age 70 fall.
- Further defined physiologically (fasting or activity status) or pharmacologically (medication, tobacco or ETOH use).
- Biochemical individuality is of particular importance in detecting asymptomatic abnormalities in older adults.
Significant homeostatic disturbances in the same individual may be detected through serial laboratory tests,
even though all individual test results may lie within normal limits of the reference interval for the entire group.
- The clinician must determine whether a value obtained reflects a normal aging change, a disease, or the
potential for disease.
- Misinterpretation of an abnormal lab value as an aging change can lead to underdiagnosis and undertreatment
in other (anemia or UTI) and overdiagnosis and overtreatment in others (hyperglycemia or asymptomatic
bacteriuria).
- At times, the result of a lab value may be within the appropriate reference range yet indicate pathology for
the older adult.
- Calculation of creatinine clearance is important in the estimation of renal function.
- Reduced renal function, particularly GFR, affects clearance of many drugs, and creat clearance provides an
index of renal function for use in choosing doses of renally eliminated or nephrotoxic drugs (such as dig, H2
blocker, lithium, and water soluble antibiotics)
- The Modiciation of Diet in Renal Disease (MDRD) and Cockcroft-Gault equations both provide useful estimates
of the GFR.
- Any risks involved in lab testing must be considered with respect to the patient’s clinical condition and weighed
pf3
pf4
pf5
pf8
pf9
pfa
pfd

Partial preview of the text

Download NR 601 Midterm Exam Study Guide: Changes with Aging and more Exams Nursing in PDF only on Docsity!

NR 601

Chapter 1: Changes with Aging - Notes Fundamental Considerations

  • Recognize that presenting features of disease/illness may be different and having a greater awareness of the impact of chronic illness on the patient.
  • Perspective is different than with younger adults. Physiological Changes with Aging
  • The clinician must be aware that all the systems interact an, in doing so, can increase the older person’s vulnerability to illness/disease.
  • During the clinical decision-making process, the clinician knowledgeable about physiological changes with aging will be less likely to undertreat a treatable condition. -Example- Use the diagnostic process to differentiate the more benign seborrheic keratosis from actinic keratosis.
  • Be informed; do not attribute a finding to the aging process alone. The elder may conclude there is no point in changing behavior, because the process is inevitable. - Three primary points:
  1. There is a reduced physiological reserve of most body systems, particularly cardiac, respiratory, and renal.
    1. There are reduced homeostatic mechanisms that fail to adjust regulatory systems such as temperature control and fluid and electrolyte balance.
    2. There is impaired immunological function: infection risk is greater, and autoimmune diseases are more prevalent. Laboratory Values in Older Adults
  • Many factors can influence lab value interpretation in the elderly, including the physiological changes with aging, the prevalence of chronic disease, changes in nutritional and fluid intake, lifestyle (including activity), and the medications taken.
  • Reference ranges therefore may be preferable. Reference ranges or intervals, such as age, sex, or race can be defined demographically. For example, the reference range for older adults might be the intervals within which 95% of persons over age 70 fall.
  • Further defined physiologically (fasting or activity status) or pharmacologically (medication, tobacco or ETOH use).
  • Biochemical individuality is of particular importance in detecting asymptomatic abnormalities in older adults. Significant homeostatic disturbances in the same individual may be detected through serial laboratory tests, even though all individual test results may lie within normal limits of the reference interval for the entire group.
  • The clinician must determine whether a value obtained reflects a normal aging change, a disease, or the potential for disease.
  • Misinterpretation of an abnormal lab value as an aging change can lead to underdiagnosis and undertreatment in other (anemia or UTI) and overdiagnosis and overtreatment in others (hyperglycemia or asymptomatic bacteriuria).
  • At times, the result of a lab value may be within the appropriate reference range yet indicate pathology for the older adult.
  • Calculation of creatinine clearance is important in the estimation of renal function.
  • Reduced renal function, particularly GFR, affects clearance of many drugs, and creat clearance provides an index of renal function for use in choosing doses of renally eliminated or nephrotoxic drugs (such as dig, H blocker, lithium, and water soluble antibiotics)
  • The Modiciation of Diet in Renal Disease (MDRD) and Cockcroft-Gault equations both provide useful estimates of the GFR.
  • Any risks involved in lab testing must be considered with respect to the patient’s clinical condition and weighed

against the test’s expected benefits. Pharmacokinetic & Pharmacodynamic Changes

  • Polypharmacy and the potential for an adverse drug reaction (ADR) are major concerns in elders.
  • Polypharmacy primary predictor for an ADR (any unwanted response).
  • The therapeutic window narrows with age. The potential for benefiting the patient measured against risk of doing harm important.
  • Pharmacokinetics (what the body does to the drug) and pharmacodynamics (what the drug does to the body) alter the dynamic processes that drugs undergo to produce therapeutic effect due to the effects of the aging process. Absorption
  • Less impact than distribution, metabolism, elimination.
  • Gastric acidity declines with age; offset by the longer contact time that occurs as transit time slows – which is more functional than physiological.
  • Presence of food and other drugs in the stomach at the same time affect drug absorption.
  • Antacids and Fe can inhibit absorption.
  • Anticholinergic meds cause a slowing of colonic motility and can result in greater absorption rates.
  • Metabolic diseases, such as thyroid disease/DM can increase or decrease transit time, can cause either increased/decreased drug absorption.
  • When the med passes through the esophagus without adequate water, can cause erosion. Distribution
  • Drug distribution is affected by aging, particularly in individuals of smaller body size, decreased body water, higher body fat.
  • Drugs distributed in water have a higher concentration in elders, and exert a more profound effect.
  • Drugs distributed fat have a wider distribution and a lesss intense effect but a more prolonged action, particularly with more adipose tissue.
  • Drugs with a high protein binding rate have a greater potential to cause an ADR in those with less body mass. Fewer receptor sites, less albumin for binding, greater plasma concentration, more free drug is available for processes.
  • Protein bound drugs can reach toxic levels if the patient is not monitored closely.
  • Drug distribution relies on the bioavailability of the drug.
  • Amount of drug that reaches systemic circulation is increased/decreased based on:
  1. Route of administration – drugs given IV/topically are more readily available than drugs admin IM/Subq/PO/rectally
  2. Soluability of the drug is influential – aqueous solutions are available more quickly than oily ones
  3. General circulation to the site of drug administration Metabolism Biotransformation occur sin all body tissues but primarily in the liver, where enzymatic activity (cytochrome P [CYP] system) alters and detoxifies the drug and prepares it for excretion.
  • Ability of the liver to metabolize drugs does not decline similarly for all meds.
  • Liver size and blood flow decrease with age, LFTs are typically normal when no disease exists. Can result in decreased first-pass metabolism.
  • Drug activity for some meds is prolonged, because drugs are metabolized and eliminated more slowly.

Chronic Illness & Functional Capacity

  • Approx 80% of those aged >65 have one chronic disease, 50% have two or more.
  • Most common: heart disease, arthritis, respiratory problems, cancer, diabetes, stroke – impair functional capacity and limit ADLs and IADLs. Chapter 1: Changes with Aging - Review Questions 1. Reference ranges or values are those intervals in which 95 % of the values fall within a specific population.
  • Reference ranges refer to a specific population (age, gender, etc.), and the majority of individuals fall within that range. 2. All of the following statements are true about renal function in the elderly except: serum creatinine is a sensitive indicator of renal impairment.
  • There are no very sensitive indicators of renal impairment. An older adult may have significant renal impairment before changes in the serum creatinine are seen.
  • True statements: 1) Reduced renal function affects the clearance of many drugs 2) The modification of diet in renal disease (MDRD) and the Cockcroft-Gault formula both provide useful estimates of the GFR 3) Estimating creatinine clearance is particularly useful when prescribing renally eliminating drugs. 3. Of all the pharmacokinetic changes associated with aging, which is the most significant?
  • Drug elimination 4. Esophageal erosions can be caused by drugs when:
    1. Insufficient fluid is taken with medications & 2) Caustic drugs are taken & 3) Drugs are taken when not in an upright position. 5. Biotransformation of drugs primarily occurs in:
  • The liver
  • Biotransformation occurs in all of these systems (kidneys, GI tract, CNS), but mostly in the liver, where drugs are detoxified and prepared for excretion. 6. Changes in renal function associated with aging are most likely to result in:
  • Prolonged half-life of drugs
  • Decreased renal function results in prolonged half-life (time it takes to eliminate the drug by half) 7. All of the following drugs are known to be nephrotoxic except:
  • Acetaminophen
  • Acetaminophen is known to be toxic to the liver
  • Nephrotoxic: NSAIDs, aminoglycosides, ACEI 8. Under reporting of symptoms occurs generally when the elderly:
  • Attribute a symptom to normal aging.
  • Older adults are less likely to report a symptom (such as pain) when they attribute it to the normal aging process. 9. The most prevalent chronic disease in the elderly is:
  • Arthritis
  • The majority of the elderly will experience musculoskeletal problems as a result of inflammation and wear and

tear. Chapter 3: Exercise in Older Adults – Notes

  • Americans more than 65 years now represent the most rapidly growing segment of the US population.
  • These numbers will increase exponentially.
  • Anticipate skyrocketing of medical costs for chronic health conditions.
  • Lifestyle interventions at any age can mitigate the effects of chronic illness.
  • There has been an increase in obesity in older adults, from 22% in 1994 to 38% in 2009-2010. Available Resources
  • Guidelines and position statements from various authorities: AHA, USPSTF, USDHHS, AGS, Healthy People 2020, The White House Conference on Aging in 2005, CDC, AOA, National Institute on Aging, CMM, ACSM, PCNA. Barriers and Facilitators to Exercise for Older Adults
  • Short term interventions, individually and in a group, face to face and by phone, were effective in increasing physical activity when delivered as part of a multifaced program of educational and cognitive behavioral participation.
  • Health education alone was not effective in this population.
  • Health care personnel recommended physical activity and an exercise prescription were effective in the short term. Patient Barriers
  • Lack of time
  • Perceived need for equipment
  • Perceived barrier to beginning exercise/physical activity
  • Disability or functional limitation
  • Unsafe neighborhood/weather conditions
  • No parks/walking trails
  • Depression
  • High BMI
  • Lack of motivation
  • Interpersonal loss or significant life event
  • Ignorance of what to do Patient Facilitators
  • Social support
  • Positive self- efficacy
  • Motivation to engage in physical activity
  • Good health, no functional limitations
  • Frequent contact with prescriber
  • Regular schedule/planned program
  • Satisfaction with program
  • Insurance incentive
  • Improvement in mobility/health condition
  • Staff (of exercise facility) support

goals. Inactive people should “start low and go slow” by gradually increasing how often and how long activities are done.

  1. Protect themselves by using appropriate gear and sports equipment, looking for safe envvironements, following rules and policies, and making sensible choices about when, where, and how to be active
  2. Be under the care of a health care provider if they have chronic conditions/symptoms. People with chronic conditions and symptoms should consult with their healthcare provider about the types and amounts of activity appropriate for them. Examples of common Health Conditions in Older Adults with Exercise Recommendations
  • Osteoarthritis: walking, aquatic activities, tai chi, resistance exercise, cycling
  • CAD: Walking, treadmill walking, cycle ergometry
  • CHF: Walking, treadmill walking, cycle ergometry
  • DM II: Resistive, aerobic, aquatic, recreational activities
  • Anxiety disorders: Walking, biking, weight lifting
  • Depression: Walking, cycling, recreational activities
  • Fibromyalgia: Aerobic, aquatic therapy, strengthening, tai chi, pilates
  • COPD: Cycle ergometer, treadmill walking; individualize
  • Chronic Venous Insufficiency: Walking, standing exercises
  • Osteoporosis: Weight bearing exercises, weight training
  • Parkinson’s Disease: Walking, treadmill walking, stationary Bike, dancing, tai chi, pilates PAD: Lower extremity exercise, treadmill walking, walking
  • Age related sleep disorders: Tai chi, walking, aquatherapy, biking
  • Dementia: Walking, recreational activities Chapter 3: Exercise in Older Adults - Questions 1) Strategies to promote increased physical activity:
  • Identify facilitators and barriers
  • Focus on the positives
  • Validate that exercise with improve/maintain pulmonary and cardiovascular function, improved flexibility, joint ROM, improved balance, will help to be independent later in life.
  • Ask, “How can I help you succeed?” 2) Additional data:
  • More complete history of occupations, hobbies, past active interest to help establish exercise plan.
  • ROS
  • Past medical and surgical history
  • Family history, health of his children
  • Preventative health care history
  • Use of OTC meds, supplements or other alternative meds 3) National guidelines to consider?
  • American College of Sports Medicine (ACSM)
  • American Heart Association (AHA)
  • US Preventative Services Task Force (USPSTF)
  • American Geriatrics Society (AGS)
  • Preventive Cardiovascular Nurses Association (PCNA)

4) Screening tools?

  • Physical Activity Readiness Questionnaire 5) POC
  • Exercise prescription with recommended frequency, intensity, time.
  • Document physical activity at every visit.
  • Measure weight and vitals at every visit.
  • Teach how to identify pulse, identify target heart rates.
  • Identify and discourage high risk activities.
  • Report any exercise induced CP, SOB, dizziness, lightheadedness, excessive fatigue, new orthopedic problems.
  • Refer to local health/physical professional if requested. Chapter 8: Chest Disorders - Notes Chapter 8: Chest Disorders - Questions 1) Additional subjective information you will ask?
  • More specifically about changing cough, hoarseness, clearing of the throat, hemopysis, anorexia, cachexia, unexplained weight loss, dyspnea, hypoxia, wheezing, recent. History of PNA, chest wall pain, dysphagia. 2) Additional objective information you will examine?
  • Patients initially may present with symptoms related to exrathoracic disease, including tracheal obstruction, esophageal obstruction with dysphagia, laryngeal nerve paralysis, phrenic nerve paralysis with elevated hemidiaphragm, sympathetic nerve paralysis, Horner’s syndrome, pleural effusion owing to lymphatic obstruction. 3) DDx:
  • TB
  • Infectious granuloma
  • PNA
  • Emphysema
  • Bronchiectasis
  • Abscess
  • Sarcoidosis
  • Pneumonitis
  • Asbestos
  • All can mimic lung cancer 4) Radiological examinations or additional diagnostic studies?
  • CXR
  • CT, preferably with contrast 5) Treatment and prescription:
  • Treatment for lung cancer is individualized.
  • Options range from surgical resection, radiation therapy, and occasionally chemotherapy are indicated for non small cell lung cancer (NSCLC).
  • Staging of the disease, patient’s functional status and histology of the tumor determine the treatments

elders with ACS is common. Dyspnea, not CP, is the most common presenting symptom of acute MI in patients over 85 years old.

  • Stable angina is substernal or precordial pressing, constriction, or heaviness precipitated by exertion and relieved with nitro.
  • Elderly or diabetic patients with altered pain perception or altered ability to localize the discomfort commonly have atypical presentation.
  • Thoracic aortic dissection has abrupt onset and severe, retrosternal tearing paint that radiates to the back and both arms.
  • PE has acute dyspnea, cough, deep pleuritic CP that may not be severe, and hemoptysis.
  • Tension pneumothorax has acute unilateral pleuritic CP and dyspnea.
  • Esophageal spasm/GERD may mimic MI, associated with eating, improves with upright position or antacids, is accompanied by cough, hoarseness, and dysphagia.
  • Acute pancreatitis has knifelike epigastric/lower chest pain radiating to the left shoulder, associated with vomiting and relieved by leaning forward.
  • MS pain is persistent and aggravated by movement, cough, or deep respiration.
  • Herpes zoster is sharp pain/paresthesia in the midthorax unilaterally. Pain may come several days before rash.
  • Anemia may predispose to ischemia.
  • Afib, recent orthopedic sx, recent immobilization, DVT, cancers are associated with PE.
  • Degenerative joint disease, anxiety disorders, GI disorders, smoking, ETOH abuse, are clues to diagnosis.
  • Serious signs are: acute confusion/anxiousness, pallor/cyanosis, diaphoresis, tachycardia, bradycardia, tachypnea, hypotension.
  • New S4/S3 murmur, signs of HF, wet crackles, suggest MI.
  • Asymmetrical BP, absent/asymmetrical extremity pulses, aortic bruit indicate aortic dissection.
  • Tracheal deviation, unilateral diminished/absent breath sounds, palpable subcutaneous crepitus, indicate pneumothorax.
  • Rapid, irregularly irregular apical pulse suggest Afib.
  • Unilateral lower extremity swelling and tenderness suggests DVT.
  • Fever suggests infectious cause.
  • Localized abdominal tenderness with guarding and rebound indicates GI origin.
  • Costochondritis pain is worse with chest movement, sneezing, or cough, not associated with fever, SOB, tachycardia, cardiopulmonary symptoms. Diffuse tenderness is usually seen over one or more costochondral joints.
  • Vesicular rash in unilateral thoracic dermatome suggest zoster. Diagnostic tests:
  • MI suspected, immediate 12 lead ECG needed. May should ST depression/elevation/T wave inversion/new LBBB/new Q waves. However ECG may not change for hours/at all.
  • Unstable anginal/non ST elevation MI shows T wave inversion, absent Q waves, and evolving ST segment changes.
  • Elevation of cardiac markers (CK-MB, troponins I/T) 4-24 hours after onset of pain indicates myocardial cell damage.
  • CXR may show pulmonary edema, pneumothorax, pleural effusion, PNA, or lung mass.
  • D-dimer and CT or V/Q scan may confirm PE.
  • Lower extremity Doppler US diagnosis DVT.
  • Additional testing guided by history/exam. DDx:
  • Previously mention emergent conditions.
  • Stable angina
  • Pericarditis
  • PNA
  • Pleurisy
  • Lung/chest malignancy
  • Esophageal spasm
  • Esophagitis
  • GERD
  • Cholecystitis
  • Pancreatitis
  • PUD
  • Costochondritis
  • Herpes zoster infection
  • Psychogenic causes Treatment:
  • Emergent conditions: ER by EMS
  • Stat intervention for suspected ACS is supplemental O2. (maintain sat above 90%), 160-325mg chewed ASA, sublingual nitro when systolic BP is able 90 mmHG and HR is greater than 50 bpm.
  • Stable angina: ASA, BB, ACEI, nitrates, statins, long acting CCB for symptom reduction if BB are ineffective/contraindicated.
  • Esophageal spasm: CCB, tricyclic antidepressants, nitrates, botulinum toxin, and dilation.
  • GERD: antacids, H2 blockers, PPI.
  • Weight loss for the overweight.
  • Costochondritis: local cool/warm packs, res, topical oral analgesics.
  • Zoster: oral antiviral meds and appropriate pain management.
  • Psychogenic causes: reassurance, cognitive-behavioral therapy, and/or antidepressants. Follow Up: Guided by diagnosis and response to treatment. Sequelae: A 20%-60% rate of unrecognized MI in the elderly with inappropriate hospital discharge and delayed treatment results in poor outcomes and increased mortality. Prevention & prophylaxis:
  • Optimize treatment of DM, HTN, CAD, Afib.
  • Daily exercise and stop smoking.
  • Reflux symptoms: control weight, elevate HOB on blocks, stay upright after meals, avoid caffeine, chocolate, spicy foods, peppermint, cigarettes, ETOH.
  • Encourage Pneumovax and Zostavax vaccines. Referral:
  • Life threatening/unstable to ER.
  • Physician consultation for uncontrolled pain, uncertain diagnosis, poor response to treatment. Education:
  • Immediately seek medical care with acute new onset CO or when change in chronic CP is experienced.

4) Tests & Screenings:

  • CBC, Hgb A1c, urine microalbumin, TSH, lipids, CMP, fecal occult blood test.
  • Mammo, colonoscopy, bone density, depression screens. 5) Recommended interventions:
  • Exercise program and weight loss
  • Dietary modification
  • Meds to reduce cardiovascular disease risk
  • Return in 4 weeks to repeat BP and weight
  • If pap is normal, does not need any further pap
  • Dx her with DM and HTN